14 research outputs found

    Characteristics of inmates stratified according to risk waist circumference (WC), risk WC = 1 when WC≥ 80 cm for women and WC≥94 cm for men.

    No full text
    Characteristics of inmates stratified according to risk waist circumference (WC), risk WC = 1 when WC≥ 80 cm for women and WC≥94 cm for men.</p

    Obesity in French Inmates: Gender Differences and Relationship with Mood, Eating Behavior and Physical Activity - Fig 1

    No full text
    <p>Body Mass Index (BMI) in kg/m<sup>2</sup> (A), weight change (B), abdominal obesity (C), and metabolic syndrome (D) in participants. White squares = women, black diamond = men, * individual underweight on prison reception.</p

    Illustration of the top gene network upregulated in the environmentally enriched (A) and control (B) groups.

    No full text
    <p>These data were generated by the Ingenuity Pathway Analysis (IPA) software using the 400 genes differentially expressed at <i>P</i><0.005. The genes marked with a red symbol are from the list of differentially expressed genes, whereas the genes marked with a white symbol are intermediary genes of the network added by the software.</p

    Behavioral effects observed in the home stall.

    No full text
    <p>Comparison between groups regarding the number of times the horses were observed in alert postures (A), with aberrant behavior (B), lying down, (C), and with the ears pointed backward (D) during scan sampling each week. C: Control horses, EE: environmentally enriched horses, W1–W5: weeks from the first to the fifth. *<i>P</i><0.05, **<i>P</i><0.01, and ***<i>P</i><0.001 (Mann–Whitney test).</p

    Medians (interquartile) of the variables of personality as a function of treatment and test session (5, 12, or 23 weeks after the initiation of treatment).

    No full text
    <p>EE: EE-treated horses.</p><p>C: control horses.</p><p>U: Mann–Whitney U value.</p><p>NS: not significant.</p><p>Medians (interquartile) of the variables of personality as a function of treatment and test session (5, 12, or 23 weeks after the initiation of treatment).</p
    corecore